107 related articles for article (PubMed ID: 18681087)
1. Intranasally administered corticosteroids and neuropsychiatric disturbances: a review of the international pharmacovigilance programme of the World Health Organization.
Pokladnikova J; Meyboom RH; Vlcek J; Edwards RI
Ann Allergy Asthma Immunol; 2008 Jul; 101(1):67-73. PubMed ID: 18681087
[TBL] [Abstract][Full Text] [Related]
2. Can intranasal corticosteroids cause migraine-like headache?
Pokladnikova J; Meyboom RH; Vlcek J; Edwards RI
Cephalalgia; 2009 Mar; 29(3):360-4. PubMed ID: 19175775
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric disorders during intranasal corticosteroid therapy.
Mansfield LE
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):333-4. PubMed ID: 18814458
[No Abstract] [Full Text] [Related]
4. Intranasal corticosteroids and adrenal suppression.
Bruni FM; De Luca G; Venturoli V; Boner AL
Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
[TBL] [Abstract][Full Text] [Related]
5. Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology.
Bielory L; Blaiss M; Fineman SM; Ledford DK; Lieberman P; Simons FE; Skoner DP; Storms WW; ;
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):514-25. PubMed ID: 16680921
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion.
Fardet L; Flahault A; Kettaneh A; Tiev KP; Généreau T; Tolédano C; Lebbé C; Cabane J
Br J Dermatol; 2007 Jul; 157(1):142-8. PubMed ID: 17501951
[TBL] [Abstract][Full Text] [Related]
7. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
Derendorf H; Meltzer EO
Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
[TBL] [Abstract][Full Text] [Related]
8. Risk of cataract among users of intranasal corticosteroids.
Derby L; Maier WC
J Allergy Clin Immunol; 2000 May; 105(5):912-6. PubMed ID: 10808171
[TBL] [Abstract][Full Text] [Related]
9. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
Gradman J; Caldwell MF; Wolthers OD
Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric adverse effects of pediatric corticosteroid use.
Drozdowicz LB; Bostwick JM
Mayo Clin Proc; 2014 Jun; 89(6):817-34. PubMed ID: 24943696
[TBL] [Abstract][Full Text] [Related]
11. [Statins--the pattern of adverse effects with empahsis on mental reactions. Data from a national and an international database].
Buajordet I; Madsen S; Olsen H
Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3210-3. PubMed ID: 9411859
[TBL] [Abstract][Full Text] [Related]
12. Safety of intranasal corticosteroid sprays during pregnancy: an updated review.
Alhussien AH; Alhedaithy RA; Alsaleh SA
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):325-333. PubMed ID: 29164323
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
[TBL] [Abstract][Full Text] [Related]
14. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric complications of treatment with corticosteroids: review with case report.
Kenna HA; Poon AW; de los Angeles CP; Koran LM
Psychiatry Clin Neurosci; 2011 Oct; 65(6):549-60. PubMed ID: 22003987
[TBL] [Abstract][Full Text] [Related]
16. Pharmacists' role in reporting adverse drug reactions in an international perspective.
van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroids: neuropsychiatric effects in children and adolescents. Neuropsychiatric adverse effects, even when inhaled.
Prescrire Int; 2009 Jun; 18(101):123. PubMed ID: 19639679
[No Abstract] [Full Text] [Related]
18. Hyponatremia in relation to treatment with antidepressants: a survey of reports in the World Health Organization data base for spontaneous reporting of adverse drug reactions.
Spigset O; Hedenmalm K
Pharmacotherapy; 1997; 17(2):348-52. PubMed ID: 9085327
[TBL] [Abstract][Full Text] [Related]
19. Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance.
Berger WE; Godfrey JW; Slater AL
Expert Opin Drug Deliv; 2007 Nov; 4(6):689-701. PubMed ID: 17970670
[TBL] [Abstract][Full Text] [Related]
20. Exogenous corticosteroid effects on mood and cognition: case presentations.
Reckart MD; Eisendrath SJ
Int J Psychosom; 1990; 37(1-4):57-61. PubMed ID: 2246106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
